Or

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment

BOSTON† June 22, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, announced today that the European Commission (EC) this week authorized a variation for IMCIVREE (setmelanotide) that allows for dosing in patients with POMC or LEPR …

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment Read More »

Male Color Cosmetics Market is projected to expand at a CAGR of 13.9% from 2022 to 2029: Future Market Insights, Inc.

Male Color Cosmetics Market is projected to expand at a CAGR of 13.9% from 2022 to 2029: Future Market Insights, Inc.

The trend of using cosmetics has gathered momentum amongst young and mid-aged men. Contrary to popular belief, the use of some of the male color cosmetics is expected to supplant the usage of the same product in women. The growing inclination of men towards personal grooming and wellness has played a defining role in driving …

Male Color Cosmetics Market is projected to expand at a CAGR of 13.9% from 2022 to 2029: Future Market Insights, Inc. Read More »

Green Pharmaceuticals Inc Issues Voluntary Nationwide Recall of SnoreStop NasoSpray Due to Microbial Contamination

Green Pharmaceuticals Inc Issues Voluntary Nationwide Recall of SnoreStop NasoSpray Due to Microbial Contamination

Summary Company Announcement Date: June 09, 2022 FDA Publish Date: June 09, 2022 Product Type: drugs Reason for Announcement: Recall Reason Description Due to microbial contamination identified as Providencia rettgeri. Company Name: Green Pharmaceuticals Inc Brand Name: Product Description: Company Announcement FOR IMMEDIATE RELEASE – June 09, 2022 – Camarillo, California, Green Pharmaceuticals Inc is …

Green Pharmaceuticals Inc Issues Voluntary Nationwide Recall of SnoreStop NasoSpray Due to Microbial Contamination Read More »